Psychology Articles

Navigating the Haze: Daily Cannabis Use vs. Addiction

Medically Reviewed by Dr. Narayanan Mooss and Ms Muktha Updated on May 14, 2026

Table of contents

Contributors

Dr. Narayanan Mooss

Ayurvedic Psychiatrist

Ms. Muktha

Clinical Psychologist

Key Take Aways

Cannabis Use Disorder (CUD) is a recognised mental health condition affecting a significant number of cannabis users, particularly daily users and young adults, where the core issue is not frequency alone but loss of control and negative impact on daily life. Chronic cannabis use alters the brain’s reward and endocannabinoid systems, leading to tolerance and a real withdrawal syndrome marked by irritability, anxiety, insomnia, and low mood after stopping. Evidence-based treatments such as CBT, Motivational Enhancement Therapy, and Contingency Management can effectively reduce dependence and improve functioning. Ayurveda views chronic cannabis use as aggravating all three doshas affecting mental clarity, emotional balance, and motivation and supports recovery through grounding routines, adaptogenic herbs like Ashwagandha, pranayama, yoga, and detoxifying practices. Seeking help early is not a failure but a practical and effective step toward restoring balance, health, and long-term wellbeing.

Full Article

Unpacking the fine line between a daily habit and a deeper dependency. 

For instance, you might wonder:

All of these questions are normal and it’s understandable that you want to support your loved one to the best of your ability

While your questions are valid, it’s also important to understand that every person’s experience with depression is unique, so there are a few things you can do to help your loved one and yourself.

Introduction: The Murky Waters of Cannabis Use

We live in a moment of profound cultural and legal shift around cannabis. Legalization has spread across dozens of US states and multiple countries. The product is mainstream, the conversation has changed, and the old stigma that surrounded any cannabis use has largely dissolved. That shift has genuinely helped many people it has opened up conversations, reduced criminal consequences, and enabled medical research. 

But it has also created a new kind of confusion. When something is normalised, the line between use and problem use gets harder to see. And cannabis has a particular problem in this regard: one of the most persistent myths about it is that it cannot be addictive. That myth is demonstrably false, and it is one the science has been correcting for years. 

According to the 2023 National Survey on Drug Use and Health, 61.8 million Americans used cannabis in the past year, and approximately 19.2 million roughly 6.8% of everyone aged 12 and older — met DSM-5 criteria for cannabis use disorder. Among 18- to 25-year-olds, the rate is nearly 16%. This is not a fringe concern. It is one of the most common substances use disorders in the United States. 

This article is not about judging cannabis use or telling you to stop. It is about helping you honestly evaluate your relationship with it understand what dependence actually looks like, why it happens, what it costs, and what is available when it becomes a problem. 

"The wound is the place where the Light enters you."

Understanding Cannabis Use Disorder (CUD)

Cannabis Use Disorder is a real, DSM-5 recognised psychiatric condition defined as a problematic pattern of cannabis use that causes clinically significant impairment or distress. The diagnosis requires at least two of eleven criteria within a twelve-month period. It is graded by severity: mild (2-3 criteria), moderate (4-5 criteria), and severe (6 or more criteria). It is not the same as occasional heavy use, and it is not simply liking cannabis a lot. It is a pattern where the use has taken on a life of its own. 

The eleven DSM-5 CUD criteria are: 

Two criteria stand out for clarity because they changed between DSM-IV and DSM-5: withdrawal and craving are now formally included. Cannabis withdrawal is clinically real, affecting roughly half of those who seek treatment for CUD, and was officially recognised as a DSM-5 diagnosis alongside CUD itself. 

How common is CUD? A meta-analysis of 21 studies found that approximately 22% of all cannabis users about 1 in 5 meet criteria for CUD. For those who use daily or near daily, the risk of developing dependence rises to roughly 1 in 3. Among young adults aged 18-25, current US data puts the CUD rate at nearly 16%. And critically: as cannabis products have become more potent and more available, prevalence has tracked upward. The 2022 NSDUH found that 7% of US adults and 30% of past-year cannabis users met DSM-5 CUD criteria. 

Important numbers: CUD is the third most common substance use disorder globally, behind alcohol and tobacco. Among people seeking treatment for drug use disorders, it accounts for a substantial proportion not because it is the most dangerous substance, but because so many people use it. The individual and public health burden is significant and growing. 

Daily Use vs. Addiction: Where's the Line?

Daily cannabis use does not automatically mean addiction. Some people use cannabis daily for medical reasons, for sleep, or as a consistent part of their lifestyle, and do not experience clinically significant impairment or distress. The diagnostic threshold is not frequency it is impact and loss of control. 

The clearest way to think about the distinction is through three questions that map onto CUD’s core mechanisms: 

If the answers to these questions produce discomfort, you are not the problem the pattern is. And patterns can change. 

Western and Eastern Perspectives

Western Psychiatry: The Neuroscience of CUD

To understand why cannabis can be addictive when cultural mythology says it cannot, you need to understand what THC delta-9-tetrahydrocannabinol, the primary psychoactive compound actually does in the brain. 

The brain has its own endocannabinoid system (ECS), a widespread network of receptors and signalling molecules that regulates mood, memory, appetite, sleep, stress response, and pain. The two primary endogenous cannabinoids anandamide and 2-arachidonoylglycerol (2-AG) act as the system’s natural modulators, fine-tuning neural activity in a retrograde (feedback) manner. THC hijacks this system by binding to CB1 receptors with much higher potency and for much longer duration than the brain’s own compounds. 

The addiction mechanism runs through the dopamine reward pathway. THC stimulates CB1 receptors in the ventral tegmental area (VTA), which releases the inhibitory brake on dopamine neurons and causes a surge of dopamine in the nucleus accumbens the brain’s reward centre. This is the same mechanism by which other addictive substances produce their reinforcing effects. Cues associated with cannabis use (the smell, the routine, certain settings) can trigger conditioned dopamine release, driving craving. 

With chronic use, the brain adapts: CB1 receptors downregulate (there are fewer of them and they respond less strongly), reducing sensitivity to both THC and the brain’s own endocannabinoids. This produces tolerance you need more to feel the same effect. It also produces withdrawal: when THC is no longer present, the now-undersupplied endocannabinoid system drives the characteristic cannabis withdrawal syndrome irritability, anxiety, insomnia, depressed mood, restlessness, decreased appetite, and physical symptoms including sweating and nausea. These symptoms typically begin within 24-48 hours of cessation, peak around days 2-6, and resolve within 2-3 weeks. 

Comorbidity is extremely common. CUD frequently co-occurs with depression, anxiety, bipolar disorder, PTSD, and psychosis and these relationships are bidirectional. The 2024 PMC comprehensive review of CUD found that in nationally representative samples, people with CUD in the past year were six times more likely to have an alcohol use disorder and nine times more likely to have any other drug use disorder. For adolescents, cannabis use significantly raises the risk of suicidal ideation (odds ratio 2.04) and attempts (OR 2.33) according to a meta-analysis by Fresán et al. (2022). 

Eastern (Ayurvedic/Yogic) Perspectives

Ayurveda’s relationship with cannabis is ancient and, notably, more honest than the modern cultural conversation: the plant (called ‘vijaya’ or ‘siddhi’) is mentioned in Ayurvedic texts going back to the 15th century, acknowledged as medicinal in narrow, specific contexts, and simultaneously classified as highly narcotic and toxic to both body and mind with habitual use. This is not prohibition thinking it is a sophisticated understanding of dose, context, and constitution that the culture of cannabis normalisation has largely skipped over. 

From the Ayurvedic standpoint, habitual cannabis use disrupts all three doshas in ways that map strikingly well onto the clinical features of CUD: 

The Yogic perspective complements this. Yoga understands addiction as a disruption in the flow of Prana (life-force energy) through the system particularly when a substance that produces short-term expansion and ease creates, over time, contraction, dependency, and a progressively narrowed sense of self. The practice of Yoga for recovery addresses this not through willpower but through rebuilding the internal states (calm, groundedness, self-awareness, equanimity) that made the substance feel necessary in the first place. 

Is It Time to Seek Help?

If the earlier questions have made you uncomfortable, that discomfort is information. It is not a verdict. Seeking help for cannabis use is not an admission of weakness or a catastrophic life event it is a decision to address something before it becomes more costly to ignore. 

Consider seeking professional assessment if any of the following are true: 

The single most important reframe here: early intervention consistently produces better outcomes than late intervention. CUD does not need to have caused serious harm to be worth treating. Recognising a pattern before it becomes entrenched is not overreaction it is good timing. 

Treatment Options

Treatment for CUD is more effective than many people assume, and more varied than simply attending a support group. The field has developed a range of evidence-based options that work the challenge is accessing them, and that challenge is real but getting better. 

Psychological Treatments

The 2024 PMC comprehensive review of CUD by Le Foll et al. confirmed that psychological treatments are the current gold standard for CUD, and specifically that CBT, Motivational Enhancement Therapy, and Contingency Management can substantially reduce cannabis use and cannabis-related problems. 

Support Groups

Marijuana Anonymous (MA) follows the same twelve-step framework as Alcoholics Anonymous, adapted for cannabis use. It provides peer connection, accountability, and the particularly important experience of meeting others who understand that cannabis can be seriously problematic which, given the cultural normalisation, is itself often what people most need. SMART Recovery is a non-twelve-step evidence-based alternative for those who prefer a skills-based approach. 

Medication

There are currently no FDA-approved medications specifically for CUD, and recent systematic reviews through May 2024 (StatPearls) show that THC analogs, CBD, gabapentin, N-acetylcysteine, and antidepressants provide inconsistent benefit. However, medication is often appropriate for co-occurring conditions treating depression, anxiety, insomnia, or ADHD that were either caused by, or are driving, the cannabis use can be a meaningful part of a comprehensive plan. A healthcare provider should assess the full picture before recommending any pharmacological approach. 

Ayurvedic and Yogic Approaches

Eastern approaches offer meaningful complementary support for CUD recovery, addressing the physical and psychological dimensions that clinical treatments may not reach. These are most valuable as adjuncts to evidence-based care, not replacements for it. 

A Personal Story: From Relaxation to Reliance

Sarah was 23 when she found cannabis. It was the year after university, the year she moved to a new city for a job she was not sure she was good enough for, the year everything felt perpetually slightly too much. A friend offered it at a party and she felt, for the first time in months, genuinely okay. Not medicated, not sedated okay. The anxiety stepped back. The constant inner commentary quieted. She slept properly that night for the first time in weeks. 

That is the thing about cannabis that nobody adequately explains when they talk about addiction: for many people, in the beginning, it works. It works really well. Sarah’s relationship with it was, for the first year, genuinely functional. Weekend nights, some evenings after particularly hard days, a deliberate choice that helped her cope with a transition she was finding genuinely difficult. 

The change was so gradual she did not notice it as it happened. The weekends became most evenings. The evenings started to include before-work mornings on particularly anxious days. And then, at some point she cannot precisely identify, it was every morning. Not large amounts just enough to take the edge off the anxiety that had become her default state. Anxiety that, she would only later understand, was increasingly caused by the cannabis itself: the withdrawal cycle that had quietly established itself without her awareness. 

She tried to stop twice on her own. The first time lasted four days before the insomnia became so severe she couldn’t function at work. The second time lasted nine days before a particularly hard week at work undid everything in one evening. Each failed attempt left her feeling worse about herself than before more convinced that she didn’t have what it took, more convinced that she genuinely needed it. 

What helped, eventually, was a conversation with her GP who did not minimise what she described and did not catastrophise it either. They talked about what she was using it for the anxiety, primarily and agreed that both needed addressing, separately and together. A referral to a CBT therapist who specialised in substance use. A structured taper rather than another cold-turkey attempt. Ashwagandha for the cortisol dysregulation. A yoga practice for the sleep. 

Sarah does not use cannabis anymore. The anxiety that drove the use is still there, in its original form the city is still demanding, the job is still high-pressure. But she has other things now. And the difference between using cannabis to cope with anxiety and not using it is smaller than it appeared from inside the cycle. That, she says, was the most surprising thing. 

FAQs:

Q: Is cannabis actually addictive? I've always been told it isn't.

Ans. This is one of the most persistent and consequential myths in the current cultural conversation about cannabis. The answer is clearly yes cannabis can be addictive, and the scientific and clinical evidence for this has been robust for years. Approximately 1 in 5 people who use cannabis will develop cannabis use disorder. For daily users, the risk rises to roughly 1 in 3. The DSM-5 formally recognises both CUD and Cannabis Withdrawal as clinical diagnoses. The specific claim that cannabis is ‘non-addictive’ typically confuses two things: the fact that cannabis does not produce the severe physical withdrawal of opioids or alcohol (which is true), and the claim that it cannot produce dependence (which is false). Psychological dependence is just as real and as clinically significant as physical dependence. 

Q: What are the withdrawal symptoms of cannabis, and how long do they last?

Ans. Cannabis withdrawal symptoms most commonly include irritability, anxiety, insomnia, depressed mood, decreased appetite, restlessness, and physical symptoms including sweating, stomach cramps, and nausea. A 2024 PMC/StatPearls clinical review confirms that symptoms typically begin within 12-24 hours of cessation, peak around days 2-6, and generally resolve within 2-3 weeks. About half of those seeking treatment for CUD experience clinically significant withdrawal. Cannabis withdrawal can mimic anxiety, mood disorders, or viral illness which is why many people don’t recognise it for what it is. Important context: the severity of withdrawal correlates with the duration, frequency, and potency of use.  

Q: Can I recover from cannabis use disorder?

Ans. Yes, absolutely and the evidence for recovery is stronger than many people realise. The 2024 PMC comprehensive review of CUD by Le Foll et al. confirms that CBT, Motivational Enhancement Therapy, and Contingency Management can substantially reduce cannabis use and cannabis-related problems. Many people recover without formal treatment, particularly those with mild to moderate CUD who have strong social support and address the underlying factors driving use. For severe CUD, professional treatment significantly improves outcomes. Recovery does not necessarily mean permanent abstinence for some people the goal is controlled use or harm reduction; for others abstinence is the most achievable and stable outcome. The choice of goal is best made with a clinician who knows your history. 

Q: How can I support a loved one who is struggling with cannabis addiction?

Ans. Three principles that the research consistently supports. First, approach the conversation with curiosity rather than accusation ‘I’ve noticed these things and I’m worried about you’ lands very differently from ‘your cannabis use is ruining your life.’ Second, express your concerns specifically and factually: what you have observed, what it has cost them, how you feel not character assessments. Third, encourage professional help without issuing ultimatums. The most effective thing a family member or friend can do is maintain the relationship while consistently and gently pointing toward support. SAMHSA’s National Helpline (1-800-662-4357) can help both the person who is using and the people around them.   

Q: Does legalization mean cannabis is safe?

Ans. Legal does not mean safe or risk-free the same is true of alcohol and tobacco. What legalization has changed is access, potency, and perceived risk. Cannabis products available in dispensaries today are significantly more potent than products from 20-30 years ago (when much of the older ‘cannabis isn’t harmful’ research was conducted), and the range of delivery methods high-concentration vapes, edibles with unpredictable absorption, concentrates has expanded the exposure profile considerably. The 2024 American Journal of Public Health analysis confirmed that legalization correlates with higher cannabis use, greater CUD prevalence, and increased psychiatric morbidity particularly among young adults and those with co-occurring mental health conditions. The legal status of cannabis does not change its neurobiological effects.  

Final Thoughts

Understanding the difference between daily cannabis use and addiction is genuinely complicated not because the science is unclear, but because the culture around cannabis has made it harder to think clearly. The normalisation has served some important purposes. But it has also made it harder for people to see when their use has crossed a line, and easier to dismiss the evidence that crossing that line has real consequences. 

Cannabis is not uniquely evil among substances. It is not uniquely harmless. It sits in the realistic, complicated middle useful for some people in some contexts, genuinely problematic for a meaningful minority of users, and increasingly potent and available in ways that change the risk calculation compared to previous generations. The 1-in-5 risk of CUD among users, rising to 1-in-3 among daily users, deserves honest acknowledgement. 

If you have read this article and feel some discomfort about what it reflects back at you, that discomfort is worth paying attention to. Not to catastrophise, not to judge, but to look at clearly. The question is not whether cannabis is good or bad in the abstract. The question is what role it is playing in your life, and whether that role is serving you. 

By staying informed, being honest with yourself, and seeking help when the pattern has moved beyond what you can manage alone, you can navigate this particular complexity and reclaim the life and calm that you are looking for.